An engineered chymotrypsin/cathepsin G site in domain I renders Bacillus thuringiensis Cry3A active against Western

Frederick S Walters1, Cheryl M Stacy, Mi Kyong Lee

  • 1Syngenta Biotechnology, Inc., Research Triangle Park, NC 27709-2257, USA. Frederick.Walters@Syngenta.com